AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CATALYST PHARMACEUTICALS, INC. Director's Dealing 2022

Sep 15, 2022

31542_dirs_2022-09-15_2354f8b5-8540-4ba2-b911-bb7c9fcb5a25.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2022-09-13

Reporting Person: MCENANY PATRICK J (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-13	Common stock, par value $0.001 per share	S	80765	$15.329	Disposed	4849452	Direct
2022-09-14	Common stock, par value $0.001 per share	S	946846	$15.414	Disposed	3902606	Direct

Footnotes

F1: Shares were sold for personal reasons. Shares were not sold as a result of any disagreement with the Company and Mr. McEnany remains a director and an officer of the Company.

F2: Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.30 to $15.385 per share.

F3: Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.25 to $15.71 per share.